Blockchain and Genomics: The law, science and policy behind EncrypGen, a new start-up.
Vasiliki Rahimzadeh of McGill and UB alumnus David Koepsell, co-founder and CEO of EncrypGen, talk in a recent webcast about blockchain and genomics with Shubha Ghosh, Crandall Melvin Professor of Law and Director, IP and Tech Commercialization Curricular Program and Syracuse Intellectual Property Law Institute (SIPLI).
David Koepsell earned his JD and PhD from UB.
Hear more from UB alumnus David Koepsell, JD, PhD
Read about EncrypGen and the other top companies bringing blockchain to healthcare.
Medical Futurist (March 2018)